Lupin secures tentative U.S. FDA approval for Ivacaftor Oral Granules
Approval paves way for Lupin’s entry into Cystic Fibrosis treatment market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cystic fibrosis
Sionna and AbbVie deal can redefine cystic fibrosis therapeutics: GlobalData
Sionna Therapeutics secures exclusive global rights to develop and commercialise advanced CF compounds, strengthening its pipeline…
Vertex could solidify dominance in cystic fibrosis market with vanza triple approval: GlobalData
Vertex’s portfolio of cystic fibrosis transmembrane conductance, regulator modulators, including Kalydeco, Orkambi,…
Network of channels inside bacterial communities can help kill bacteria faster: Study
This could change the way that pharma companies approach treatment strategies and help design new methods for delivering drugs to…
Rare Diseases: Awaiting renewed focus
India needs to make significant investments in R&D, policy reforms, and measures to enable affordability and accessibility of…
FDA approves new breakthrough therapy for cystic fibrosis
Treatment approved for approximately 90 per cent of patients with cystic fibrosis, many of whom had no approved therapeutic…